Machine Learning-Based Algorithm to Predict Procedural Success in a Large European Cohort of Hybrid Chronic Total Occlusion Percutaneous Coronary Interventions.

Journal: The American journal of cardiology
Published Date:

Abstract

CTOs are frequently encountered in patients undergoing invasive coronary angiography. Even though technical progress in CTO-PCI and enhanced skills of dedicated operators have led to substantial procedural improvement, the success of the intervention is still lower than in non-CTO PCI. Moreover, the scores developed to appraise lesion complexity and predict procedural outcomes have shown suboptimal discriminatory performance when applied to unselected cohorts. Accordingly, we sought to develop a machine learning (ML)-based model integrating clinical and angiographic characteristics to predict procedural success of chronic total occlusion (CTO)-percutaneous coronary intervention(PCI). Different ML-models were trained on a European multicenter cohort of 8904 patients undergoing attempted CTO-PCI according to the hybrid algorithm (randomly divided into a training set [75%] and a test set [25%]). Sixteen clinical and 16 angiographic variables routinely assessed were used to inform the models; procedural volume of each center was also considered together with 3 angiographic complexity scores (namely, J-CTO, PROGRESS-CTO and RECHARGE scores). The area under the curve (AUC) of the receiver operating characteristic curve was employed, as metric score. The performance of the model was also compared with that of 3 existing complexity scores. The best selected ML-model (Light Gradient Boosting Machine [LightGBM]) for procedural success prediction showed an AUC of 0.82 and 0.73 in the training and test set, respectively. The accuracy of the ML-based model outperformed those of the conventional scores (J-CTO AUC 0.66, PROGRESS-CTO AUC 0.62, RECHARGE AUC 0.64, p-value <0.01 for all the pairwise comparisons). In conclusion, the implementation of a ML-based model to predict procedural success in CTO-PCIs showed good prediction accuracy, thus potentially providing new elements for a tailored management. Prospective validation studies should be conducted in real-world settings, integrating ML-based model into operator decision-making processes in order to validate this new approach.

Authors

  • Alice Moroni
    HartCentrum Bonheiden-Lier, Imelda Hospital, Bonheiden, Belgium.
  • Andrea Mascaretti
    Department of Theoretical and Scientific Data Science, Scuola Superiore Internazionale di Studi Avanzati, Trieste, Italy.
  • Jo Dens
    Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Paul Knaapen
    Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.
  • Alexander Nap
    Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Yvemarie B O Somsen
    Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Johan Bennett
    Department of Cardiovascular Medicine, UZ Leuven, Leuven, Belgium.
  • Claudiu Ungureanu
    Department of Cardiology, Hôpital de Jolimont, La Louvière, Belgium.
  • Yoann Bataille
    Department of Cardiology, Jessa Ziekenhuis, Hasselt, Belgium.
  • Steven Haine
    Department of Cardiology, Antwerp University Hospital, Edegem, and University of Antwerp, Belgium.
  • Patrick Coussement
    Department of Cardiology, AZ Sint-Jan Brugge, Brugge, Belgium.
  • Peter Kayaert
    Department of Cardiology, Jessa Ziekenhuis, Hasselt, Belgium.
  • Alexander Avran
    Department of Interventional Cardiology, Valenciennes Hospital, Valenciennes, France.
  • Jeroen Sonck
    Cardiovascular Center OLV Aalst, Belgium.
  • Carlos Collet
    Cardiovascular Center OLV Aalst, Belgium.
  • Stéphane Carlier
    Department of Cardiology, Hopital Ambroise Paré and Université de Mons, Mons, Belgium.
  • Giovanni Vescovo
    Interventional Cardiology, Department of Cardio-Thoracic and Vascular Sciences, Ospedale dell'Angelo, Venice, Italy.
  • Giacomo Avesani
    Dipartimento di Diagnostica Per Immagini, Radioterapia Oncologica Ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Mohaned Egred
    Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
  • James C Spratt
    Department of Interventional Cardiology, St. George's, University of London, London, United Kingdom.
  • Roberto Diletti
    Department of Cardiology, Thorax Center, Erasmus MC Cardiovascular Institute, Rotterdam, the Netherlands.
  • Omer Goktekin
    Memorial Bahcelievler Hospital, Istanbul, Turkey.
  • Nicolas Boudou
    Interventional Cardiology Department, Clinique Saint-Augustin-Elsan, Bordeaux, France.
  • Carlo Di Mario
  • Kambis Mashayekhi
    Division of Cardiology and Angiology II, University Heart Center Freiburg - Bad Krozingen, and Division of Internal Medicine and Cardiology, Heart Center Lahr, Germany (K.M.).
  • Pierfrancesco Agostoni
    HartCentrum, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium.
  • Carlo Zivelonghi
    HartCentrum, Ziekenhuis aan de Stroom (ZAS) Middelheim, Antwerp, Belgium. Electronic address: carlo.zivelonghi@gmail.com.